1. Diabetic retinopathy is independently associated with increased risk of intubation: A single centre cohort study of patients with diabetes hospitalised with COVID-19. (January 2021) Authors: Corcillo, Antonella; Cohen, Siew; Li, Adrian; Crane, James; Kariyawasam, Dulmini; Karalliedde, Janaka Journal: Diabetes research and clinical practice Issue: Volume 171(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Effectiveness and cost of integrating a pragmatic pathway for prescribing liraglutide 3.0 mg in obesity services (STRIVE study): study protocol of an open-label, real-world, randomised, controlled trial. Issue 2 (13th February 2020) Authors: Papamargaritis, Dimitris; Al-Najim, Werd; Lim, Jonathan; Crane, James; Lean, Mike; le Roux, Carel; McGowan, Barbara; O'Shea, Donal; Webb, David; Wilding, John; Davies, Melanie J Journal: BMJ open Issue: Volume 10:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Oxytocin receptor activation in the basolateral complex of the amygdala enhances discrimination between discrete cues and promotes configural processing of cues. (October 2018) Authors: Fam, Justine; Holmes, Nathan; Delaney, Andrew; Crane, James; Westbrook, R. Frederick Journal: Psychoneuroendocrinology Issue: Volume 96(2018) Page Start: 84 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. The GLP-1 agonist, liraglutide, as a pharmacotherapy for obesity. (March 2016) Authors: Crane, James; McGowan, Barbara Journal: Therapeutic advances in chronic disease Issue: Volume 7:Number 2(2016:Mar.) Page Start: 92 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗